Press-release for stocks in the health technology sector related to pharma

Prices are updated after-hours

sector : Health technology tags : Pharma

save search

Zealand Pharma Partners with Benchling to Advance R&D of Engineered Peptide Medicines
Published: 2024-04-23 (Crawled : 08:00) - prnewswire.com
ZEAL | $17.59 1.21% -4.21%

Health Technology

| Email alert Add to watchlist
pharma

HIV Drugs Market size is set to grow by USD 10.47 billion from 2023-2027, AbbVie Inc., Aspen Pharmacare Holdings Ltd and Aurobindo Pharma Ltd., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630

Health Technology

| -3.74% | O: -3.15% H: 0.0% C: -0.61%
VTRS | News A | $11.36 0.98% 0.97% 4.7M

Health Technology

| 0.98% | O: 0.0% H: 1.33% C: 0.98%
GSK | News | $41.24 1.6% 0.0% 2.3M

Health Technology

| 1.6% | O: 0.17% H: 1.48% C: 1.43%
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 0.98% | O: 0.42% H: 1.06% C: 0.56%
pharma abbvie set hiv key market

Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan
Published: 2024-04-22 (Crawled : 18:00) - biospace.com/
LTRN | News | $5.8 1.4% 1.38% 130K

Health Technology

| 8.05% | O: 6.74% H: 5.26% C: 0.35%
lung pharma japan approval cancer cell for trial

Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
Published: 2024-04-22 (Crawled : 12:00) - globenewswire.com
OCUP | News | $1.53 1.33% 1.31% 140K

Health Technology

| -7.78% | O: -1.8% H: 0.0% C: -7.93%
apx3330 pharma presentation meeting

23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer
Published: 2024-04-22 (Crawled : 05:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| 2.56% | O: 0.85% H: 0.0% C: 0.0%
pharma cancer for

Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%

Health Technology

| Email alert Add to watchlist
pharma management for

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%

Health Technology

| Email alert Add to watchlist
pharma

Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| 3.25% | O: 0.83% H: 1.35% C: 1.2%
RPRX | $27.82 0.0% 3.5M

Health Technology

| 0.96% | O: 1.07% H: 1.22% C: 1.11%
first pharma royalty financial results

Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
LUMO | $2.79 4.1% 3.94% 17K

Health Technology

| 11.11% | O: 5.16% H: 6.79% C: -2.26%
pharma presentation for medical

Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
EVOK | $0.469 3.08% 2.99% 4.8K

Health Technology

| Email alert Add to watchlist
pharma key

Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
EVOK | $0.469 3.08% 2.99% 4.8K

Health Technology

| Email alert Add to watchlist
pharma key

Royalty Pharma Declares Second Quarter 2024 Dividend
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| 3.17% | O: -0.04% H: 0.28% C: -0.16%
RPRX | $27.82 0.0% 3.5M

Health Technology

| -0.5% | O: -1.5% H: 0.84% C: 0.25%
pharma royalty

Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules
Published: 2024-04-17 (Crawled : 11:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| 3.17% | O: -0.04% H: 0.28% C: -0.16%
reminyl pharma acquisition

HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
HOOK | $0.7801 10.34% 9.37% 790K

Health Technology

| -4.93% | O: 0.01% H: 1.23% C: -6.17%
award pharma nasdaq grant

Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568
Published: 2024-04-16 (Crawled : 07:00) - globenewswire.com
NBIX | News M | $140.11 4.83% 4.6% 1.6M

Health Technology

| 4.02% | O: -2.15% H: 2.58% C: 0.92%
nbi-1117 pharma candidate schizophrenia

BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-15 (Crawled : 16:00) - biospace.com/
BETR | $0.4245 0.83% 0.82% 520K

n/a

| -5.7% | O: -1.21% H: 1.36% C: -4.41%
BETRF | $0.0745 -3.71% 550

Health Technology

| -3.65% | O: -8.49% H: 11.31% C: 11.31%
pharma conference

Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
ATHA | $2.035 -2.63% -2.7% 85K

Health Technology